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ABSTRACT
The novel complexes [Pd(L-L’)(SR)CI] where L-L" is Ph2PCH2CH2PPh2 (dppe) or
Ph2AsCH2CH2PPh2 (dadpe) and RSH is glutathione, L-cysteine, or N-acetyI-L-cysteine, have
been prepared and characterised. Their structures in the solid-state and in solution are
discussed. The introduction of cysteine or glutathione as a ligand in these complexes greatly
improved their aqueous solubility compared with the hydrophobic parent dichlom complexes. The
cytotoxicities of the glutathione complexes towards the cell-lines L1210, ADJ/PC6 and CH1 were
investigated. Their cytotoxicities towards L1210 cells were comparable to those of the parent
dichloro complexes.
ABBREVIATIONS
dppe 1,2-diphenylphosphinoethane; dadpe 1-diphenylarsino-2-diphenylphosphinoethane
H2dmsa dimercaptosuccinic acid; GSH glutathione, 7-L-Glu-L-Cys-Gly
CysH L-cysteine; N-AcCysH N-acetyI-L-cysteine
IC50 concentration required to kill 50% of the cells
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INTRODUCTION
Cytotoxic Phosphinoarsino andDiphosphino Pd(II) Complexes
ofThiolate Amino Acids and Gluthathione
Certain tetmhedml diphosphine complexes of Group 11 metals, such as [Au(dppe)2]CI are highly
cytotoxic and exhibit anticancer activity in some model systems. They appear to act by a
different mechanism to cisplatin, cis-[PtCI2(NH3)2], attacking proteins as well as DNA. Recently
we have sought to extend this series of complexes to include square-planar diphosphine
complexes.2 One of the major objectives is to increase the aqueous solubility of complexes
containing hydrophobic diphosphine ligands, and in this paper we use thiolate amino acid
derivatives for this purpose.
The formation of Pd(ll) complexes with amino acids and peptides has been reviewed by Pettit
and Bezer.3 There have been few studies on the formation of Pd(ll) complexes with glutathione
(7-L-Glu-L-Cys-Gly),,4,5 although there are some reports of 1H NMR studies on binding of GSH to
other metals, eg Me3Pb,6 mixed ligand complexes of Cd(II)(NTA),7 and gold (I) drugs.
Rabensein and coworkers have carried out 1H and 13C NMR spectroscopic sudies on the
binding, formation constants, and ligand exchange reactions of MeHg(ll)-thiol complexes with
thiols such as glutathione, cysteine. There are no X-ray structures of metal GSH complexes,
however a dimeric Cu(ll) complex of GSSG has been crystallogmphically characterised. 12 The
solid state structure of the complex of Pd(ll) with S-methyI-L-cysteine has been reported. The
geometry about the metal is square planar with S, N coordination as has been found for Pd
complexes of S-methyI-L-cysteine sulphoxideTM and S-methyI-L-cysteine methyl ester. 15
We report here the preparation and characterization of novel mixed ligand Pd(ll) complexes
containing cysteine, N-acetylcysteine or glutathione, and diphosphine or arsinophosphines as
ligands, and their cytotoxicity against L1210, ADJ/PC6 and CH1 cell-lines.
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EXPERIMENTAL SECTION
1,2-Bis(diphenylphosphino)-ethane (dppe) and 1-diphenylphosphino-2-diphenylarsinoethane
(dadpe) were pumhased from Strem Chemicals. L-Cysteine (free base), N-acetyI-L-cysteine, and
glutathione were obtained from Sigma. The compounds [Pd(L-L’)CI2] (L-L" dppe, dadpe) were
prepared from dichloro-l,5-cyclooctadiene-palladium(ll) (Aldrich) as previously described for the
analogous Pt complex,16 and isolated as CHCI3 solvates, [Pd(L-L’)CI2].2CHCI3.
Physical measurements
500 MHz 1H NMR spectra were recorded at ambient temperature (ca. 23C) on a JEOL GSX500
instrument. 13C{1H} NMR spectra were recorded on a JEOL GSX270 spectrometer operating at
71.9 MHz; 81 MHz 31p{1H} spectra were acquired on a Bruker WM200 spectrometer. 1H and
13C chemical shifts were referenced to sodium trimethylsilyl-2,2,3,3-d4-propionate (TSP), and
31p shifts to external 85% H3PO4.
Measurements of pH* (pH meter reading in D20 solutions) were made on a Corning pH meter
equipped with an Aldrich combination microelectrode. Adjustments of pH* were made with DCI or
NaOD.
IR spectra were recorded on a Perkin-Elmer 1330 instrument as Nujol mulls for GSH and its
complexes, and [Pd(dadpe)(NAcCys)CI], and as KBr discs for CysH and [Pd(dppe)(Cys)CI]. For
21l/’oL 2, No. 1, 1995 Cytotoxic Phosphinoarsino andDiphosphino Pd(lI) Complexes
ofThiolate Amino Acids and Gluthathione
[Pd(dadpe)(Cys)CI] a KBr disc was used between 4000 and 600 cm"1 and a Nujol mull between
600 and 200 cm’l.
Mass spectra (fast atom bombardment) were recorded using a VG ZAB-SE mass spectrometer at
the University of London School of Pharmacy (ULIRS) with samples in an MNOBA (meta-nitro-
ortho-benzoic acid) matrix. Elemental analyses were carried out by the micmanalysis service at
University College London.
Thin layer chromatography was carried out on RPS-F plates (Anachem) using 1:1 EtOH:H20 as
eluant. Cysteine complexes were dissolved in EtOH or H20 prior to elution and glutathione
complexes in H20.
Synthesis of [Pd(dppe)(Cy$.HCl)Cl].H20 (1)
To a suspension of [Pd(dppe)CI2].2CHCI3 (0.099 g, 0.12 mmol) in aq. EtOH (30 mL, 1:2) was
added an aqueous solution (5 mL) of L-CysH (0.014 g, 0.12 mmol). After stirring at room
temperature for 1 h, the solution had become yellow with some solid present. It was filtered, then
concentrated affording a yellowsolid 1 (0.0145 g, 17%), m.p. 170 C.
(Found: C, 47.0; H, 4.6; N, 2.2; P, 9.1%; C29H33NO3SP2CI2Pd requires C, 48.7; H, 4.65; N,
2.0; P, 8.7 %); IR daa, Table 1; 3p and 1H NMR data, Tables 2 and 3; m/z 624
{[Pd(dppe)Cys]+}. Tic: Rf 0.64 EtOH solution; Rf 0.58 and faint spot at Rf 0.83 aq. solution)
Synthesis of [Pd(dadpeXCys.HCl)Cl ] .H20 (2)
To a suspension of [Pd(dadpe)CI2].2CHCI3 (0.202 g, 0.235 mmol) in aq. EtOH (30 mL, 1:2) was
added L-CysH (0.028 g, 0.23 mmole) in 5 mL H20. After stirring at room temperature for I h, the
almost clear yellow solution was filtered and the filtrate concentrated affording an orange-yellow
solid 2. (0.137 g, 77%).
(Found" C, 45.5; H, 4.3; N, 1.7; P, 4.6 %; C29H33NO3SPAsCI2Pd requires: C, 45.9 H, 4.4; N,
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1.85; P, 4.1%); IR data, Table 1; 31p NMR data, Table 2; m/z 670 {[Pd(dadpe)(CysH)]+ + 1}.
Tic :Rf 0.71 and 0.69 for EtOH and H20 solutions, respectively)
Synthesis of [Pd(dppe)(GS.HCl)Cl].3H20 (3)
To a suspension of [Pd(dppe)CI2].2CHCI3 (0.166 g, 0.203 mmol) in aq. EtOH (30 mL, 1:2) was
added an aqueous solution (10 mL) of GSH (0.071 g, 0.229 mmol). After stirring at room
temperature for 1 h, the solution had become almost clear yellow. It was filtered, then
concentrated affording a yellowsolid 3 (0.141 g, 73.9 %), m.p. 125 C.
(Found: C, 45.6; H, 4.8; N, 4.45 %; C36H47N309PdSCI2P2 requires: C, 46.2; H, 5.0; N, 4.5 %);
IR data, Table 1; 3p, H and 3C NMR data, Tables 2, 3 and 4; m/z 811 {[Pd(dppe)(GSH)]+ +
1}; tic, Rf 0.08 for H20 solution)
Synthesis of [Pd(dadpe)(GS.HCl)Cl].3H20 (4)
To a suspension of [Pd(dadpe)CI2].2CHCI3 (0.209 g, 0.245 mmol) in aq. EtOH (30 mL, 1:2) was
added GSH (0.074 g, 0.241 mmole) in 10 mL H20. After stirring at room temperature for 1 h, the
resultant clear yellow solution was filtered and the filtrate concentrated affording an orange-yellow
solid 4 (0.137 g, 58 %), m.p. 155-160 C, (Found: C, 43.3; H, 4.6; N, 4.3; CI, 7.1; P, 3.4 %;
C36H47N3OgPdSCI2PAs requires: C, 44.1; H, 4.8; N, 4.3; CI, 7.2; P, 3.2 %); IR data, Table 1;
3p and 3C NMR data, Tables 2 and 4; m/z 855 {[Pd(dadpe)(GSH)]+ + 1}; tic "N 0.15 tor
H20 solution (streaking).
Synthesis of [Pd(dadpeXN-AcCys)CI]. H20 (5;)
To a suspension of [Pd(dadpe)CI2].2CHCI3 (0.10 g, 0.116 mmol) in EtOH (25 mL) was added an
aqueous solution (3 mL) of N-Ac Cys (0.019 g, 0.116 mmol). After stirring at room temperature for
30 min, the solution had become almost clear yellow. It was filtered, then concentrated in vacuo
affording a yellowsolid 5 (0.053g, 60.8%), m.p. 145-150 C.
(Found, C, 48.6; H, 4.7; N, 1.9; P, 4.3 %. C31H34NO4SPdPAsCI requires: C, 48.7; H, 4.5; N, 1.8;
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P, 4.1%); 31p NMR data, Table 2.
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Reactions of [Pd(dppe)CI2].2CHCI3 with NAcCysH were also carried out, but it was not possible
to isolate a pure product.
Biological testing
The cytotoxicities of aqueous solutions of the glutathione complexes 3 and 4 against murine
L1210 and ADJ/PC6, and normal CH1 (human ovarian cells) cell-lines were determined as
described previously.2
RESULTS AND DISCUSSION
There am a few previous reports of Pd(ll) complexes with anticancer activity.17, In general Pd(ll)
complexes are much more kinetically labile than those of Pt(ll) and therefore less likely to arrive
at the target site (e.g. DNA) with the original ligands still bound. However in the present case
intracellular ligand release might still result in activity since the ligands dppe and dadpe are
themselves cytotoxic.2 The main aim of the present work was to increase the aqueous solubility
of Pd(ll) complexes containing these hydmphobic ligands whilst retaining their cytotoxicity.
We prepared the novel complexes [Pd(L-L)(Cys)CI] (L-L" dppe 1; dadpe 2), [Pd(L-L’)(GS)CI] (L-
L" dppe 3; dadpe 4) and [Pd(L-L)(N-AcCys)CI] (L-L" dadpe 5) by addition of an aqueous
solution of the thiol ligand to an aqueous ethanolic suspension of [Pd(L-L)CI2]. The complexes
have satisfactory element analyses, except for the low C content of complex 1. The mass
spectra of complexes 1 to 4 were consistent with the proposed formulae and the presence of
monomeric structures in the solid state. Only for complex 2, [Pd(dadpe)(Cys.HCI)CI], was a
significant amount of a higher molecular mass ion observed, and this was only a minor
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TABLE 1. IR data for [Pd(L-L’)(Cys.HCI)CI] (L-L" dppe 1; dadpe 2) and [Pd(L-L’)(GS.HCI)CI]
(L-L" dppe 3; dadpe 4) and the thiol ligands. (vs very strong, s strong, rn medium, w weak, br
broad)
CysH 1 2 GSH 3 4 Assignment
3460 (m,br) 3430 (m,br) 3450 (m,br)
3180 vs
3000 (s, br) 3060 (m, br) 3050 w
3330 vs
3240 vs
3120 s
3400 (w,br) 3400 (w,br) v(O-H) of H20
1 1
v(N-H)
2550 rn absent absent 2515 s absent absent v(S-H)
1725 (s, br) 1725 (s, br) 1710 vs 1720 m 1715 (m, br) v(C=O)
1600 (vs, br) 1635 (vs, br) 1625 (m, br) 1650 vs 1650 (s, br) 1650 (m, br) d(NH3+)
1580 (vs, br) absent absent
1515 s 1480 s 1470 m
1415 s 1430 s 1425 s
1600 (s, br) absent absent v(COO’)asym
1525 (s, br) 1515 (w, br) 1510 (w, br) 5(NH3+)sym
1405 rn 1 1 v(COO’)sym /
v(C-O)/
5(O-H) in-plane
940 s 930 (w, br) absent 920 s absent absent 5(S-H)/(O-H)
out-of-plane
1 Overlap with Nujol
component. The mass spectrum of 1 showed a parent molecular ion (p.m.i) of m/e 624
corresponding to [Pd(dppe)(Cys)]+ which is also the most intense or base peak. For 2 the base
peak was at m/z 670, which is assigned to [Pd(dadpe)(CysH)]+ +1; there were also a number of
higher mass peaks, the most abundant being m/z 1261 ([Pd(dadpe)(CysH)]2+ Ph +1; 20%
intensity of base peak). Complexes 3 and 4 showed p.m.i.’s at m/z 811 and 855 corresponding
to [Pd(dppe)(GSH)]+ + 1 and [Pd(dadpe)(GSH)]+ + 1, respectively. The base peaks for these two
complexes are assignable to a species [Pd(L-L)(SH2)]+ + 1. The IR spectra for complexes 1-4,
Table 1, showed the disappearance of the SH stretch confirming that the thiol ligands are
coordinated via S.
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TABLE 2.31 p{1H} NMR data for [Pd(L-L’)(Cys.HCI)CI], and [Pd(L-L’)(GSH.HCI)CI] in D20 at
various pH* values and in d6-dmso, and for [Pd(dadpe)(NAc-Cys)CI] 5; in EtOH/D20. (L-L"
dppe, dadpe) and some tentative assignments.
Complex Solvent pH* ,5 (ppm) J (Hz) Group trans to P
[Pd(dppe)(Cys)CI] 1
[Pd(dadpe)(Cys)CI] 2
[Pd(dppe)(GS)CI] 3
[Pd(dadpe)(GS)CI] 4
[Pd(dadpe)(NAc-Cys)CI] 5
D20 2.7 65.4 S bridging
64.2 18.6 CI/N
55.7 18.7 S
7.1 63.3 19.0 CI/N
54.9 19.4 S
12.2 63.3 19.0 CI/N
54.9 19.1 S
d6-dmso 62.6 22.9 CI/N
51.0 23.0 S
D20
d6-dmso
D20
d6-dmso
2.6 68.5 (br) S bridging
64.9 CI/N
58.7 S
7.1 64.3 (80%) CI/N
58.2 (20%) S
12.2 64.3 (90%) CI/N
5a.o (10%) S
63.7 CI/N
2.5 65.1 S bridging
7.1 64.8 S bridging
12.5 61.0, 52.2, 49.5
(50:30:20%)
66.4 11.9 CI/N
54.2 11.9 S
67.4, 56.9 (weak)
D20
d6-dmso
2.5
7.1
12.4
67.5 CI/N
67.2 CI/N
63.7, 62.9, 62.4
68.8 (92%) CI/N
58.8 (8%) s
EtOH/D20 67.2, 66.2-
64.2 (weak)
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TABLE 3. 1H NMR data for the complexes [Pd(dppe)(Cys)CI] 1 and [Pd(dppe)(GS)CI] 3 in D20.
(dd doublet of doublets, triplet, m multiplet, br broad &Vl/2 40-100 Hz).
Complex 6 (ppm) (ppm) Assignment
[Pd(dppe)(Cys)CI] 1 pH* 2.7 pH* 7.1
7.875, 7.675 7.825, 7.733 C6H5 of dppe
7.600, 7.574 rn 7.648, 7.574 m
4.224 rn 3.814 m Cys o-CH
2.942 rn 2.862 m Cys -CH2
2.718 rn 2.778, 2.711 dppe CH2
2.607 rn
[Pd(dppe)(GS)CI] 3 pH* 2.5 pH* 7.1
7.88, 7.68 7.89, 7.64 C6H5-of dppe
7.55, 7.47 7.50, 7.41
7.39 br 7.34 br
3.763 q 3.657 Gly-cz CH2
3.724 dd 3.570 G]u-0 CH
3.388
3.32 br 3.27 br Cys- CH2
2.85 br 2.82 br Glu-7CH2
2.52 br 2.443 br Glu- CH2
2.231,2.047 rn 2.22, 2.00 rn CH2 of dppe
1.966 rn
In solution the structures of these complexes are potentially complicated since Pd(ll) can form
strong bonds to CI’, thiolate S, carboxylate O, and amino or deprotonated amide N atoms. We
made some tentative structural assignments from 31p, 1H and 13C NMR data. 31p NMR is
particularly useful for dppe complexes since the presence of a 31p.31p coupling indicates a
complex with non-equivalent coordinated P atoms and the shifts are a guide to the nature of the
trans ligand, based on those of previously-reported chlom ( 64.2 ppm) and S-bound dmsa (
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TABLE 4(a).13C{1H} NMR data for [Pd(L-L’)(GS)CI] (L-L" dppe 3, dadpe 4) in D20 at acidic
and neutral pH* values. A,5 5(pH* 7.2)- 5(pH* 1.8) and some tentative assignments.
Complex 6(complex) /)(GSH)
[Pd(dppe)(GS)CI] 3
pH* 1.8 pH* 7.2
176.1 176.6 0.5 0.4
175.5 178.4 2.9 3.3
175.1 176.4 1.3 1.6
173.0 172.0 -0.8 -1.0
136.5, 135.8 136.6, 135.9, 135.5
132.7, 132.5 132.9, 132.5 (d 6.4 Hz)
129.0, 128.2, 127.3 129.2 br, 128.1,127.3
56.8 56.8 0 0.1
55.6 56.8 1.2 1.2
43.8 46.1 2.3 2.2
35.1 35.4 0.3 0.2
34.1 34.5 0.4 0.4
30.1 d 30.0 (d 36.7 Hz)
28.4 29.0 0.6 0.5
[Pd(dadpe)(GS)CI] 4
pH* 1.8 pH* 7.2
176.0 176.7 0.7 0.4
175.5 178.3 2.8 3.3
175.0 176.4 1.4 1.6
173.3 172.3 -1.8 -1.0
172.9 172.0 -0.9
172.5 171.5 -1.0
136.7, 136.3 136.9, 136.8
135.6, 135.2 136.3, 136.1, 135.9
56.8 56.8 0 0.1
55.4 56.8 1.4 1.2
43.8 46.0 2.2 2.2
36.7 0.2
36.5 (d 14.4 Hz)
34.0 34.4 0.4 0.4
31.0 (d 27.3 Hz)
28.4 29.0 0.6 0.5
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Assignment
Glu lr-CONH
Gly- (xCOOH
Glu- (xCOOH
Cys- (xCONH
dppe Ph
Cys- xCH
Glu- (xCH
Gly- xCH2
Cys- CH2
Glu-TCH2
CH2-P
Glu- I]CH2
Glu ,-CONH
Gly- xCOOH
Glu-
Cys- xCONH
dadpe Ph
Cys- oCH
Glu- xCH
Gly- (xCH2
Cys- CH2
CH2-As
Glu-tCH2
CH2-P
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TABLE 4(b). 13C Coordination chemical shifts (ccs) for [Pd(dppe)(GS)CI] 3 and
[Pd(dadpe)(GS)CI] 4 at pH* 1.8 and 7.2 (upfield shifts are negative)
Group
Coordination chemical shifts (ppm)
Complex 3 Complex 4
pH* 1.8 pH*= 7.2 pH*= 1.8 pH* 7.2
Glu 7-CONH 1.2 1.1 1.3 1.0
Gly- oCOOH -0.2 -0.6 -0.2 -0.7
Glu- zCOOH 0 -0.3 -0.1 -0.3
Cys- (zCONH -2.2 -2.4
-1.9 -2.1
-2.3 -2.4
-2.7 -2.9
Cys-CH -1.5 -1.6 -1.5 -1.6
Glu- (zCH -0.1 -0.1 -0.3 -0.1
Gly- oCH2 -0.1 0 -0.1 -0.1
1 Cys-CH2 7.0 7.1 8.6
Glu-H2 0.3 0.3 0.2 0.2
Glu- CH2 0 0.1 0 0.1
1 uncertain unassignment
54.4 ppm) complexes. However based on the present data alone a distinction between N and CI
binding was not possible.
31p NMR data are given in Table 2. For complex 1 at low pH* two species were present in
solution, one of which contained magnetically equivalent P atoms ( = 65.4; la) and the other (
64.2, 55.7; lb) non-equivalent P atoms. The coupling constant of 19 Hz is typical of 3j (pp)
values in square-planar complexes.2 At higher pH* and in d6-dmso only lb was present. This
suggests that complex la is a symmetrical thiolate S-bridged dimer [Pd(dppe)(wCys-S)]2. It
seems likely that complex lb is present in dmso as [Pd(dppe)(Cys-S)CI] and in aqueous solution
lb has a chelated Cys ligand as in [Pd(dppe)(Cys-S,N)]. At high pH*, the spectrum of 2 showed
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two resonances at 64.3 and 58.0 ppm. Since them is only one P atom in the dadpe ligand, these
are assigned to two isomeric species, the latter to a P trans to S by analogy with
[Pd(dadpe)(dmsa)] (57.3 ppm)2, and the former to the predominant isomer containing P trans to N
or CI. At low pH* a third peak is present assignable to a species containing bridging S, and the
intensity of the peak for the major isomer increased by a factor of ca. 4.
A pure product was not isolated from the reaction of [Pd(dppe)CI2] with N-acetyI-L-cysteine; the
31p NMR spectrum of an aqueous EtOH solution of the crude product showed that only a
species containing magnetically equivalent P atoms was present. Complex 5,
[Pd(dadpe)(NAcCys)CI] gave two resonances at 76.2 ppm and 66.2 ppm in aqueous EtOH.
1H NMR data for complexes 1 and 3 are listed in Table 3. For complex 1 at low pH* there are
resonances at 4.22 and 2.94 ppm due to the z-CH and -CH2 of coordinated Cys. At neutral pH,
these are less shifted with respect to unbound Cys, in particular that of the -CH, suggesting that
either the carboxylate or the amino group is uncoordinated and protonates at low pH. At both pH
values, the 1H NMR spectra showed minor signals characteristic of cystine and free Cys which
shifted slightly downfield as the pH* was increased. The spectra at low pH* also showed four
multiplets at 7.88-7.57 ppm due to the C6H5 protons of dppe, and a broad multiplet at 2.718
p.p.m, due to the CH2 protons of dppe. At higher pH* the Ph resonances were unchanged and
the CH2 protons gave rise to three multiplets. The spectrum of 3 at low pH* showed a quartet
assignable to Gly-(z-CH2 protons and a doublet of doublets due to Glu-0CH; these were sharp
and overlapping. Other resonances assigned to GS in this complex were broad, i.e. those of the
Cys-CH2 protons and of Glu-TCH2 and Glu-JCH2. No resonance due to Cys-o-CH was
observable. At neutral pH* the resonances for Glu-(zCH appeared as two doublet of doublets with
a shift difference of 93.8 Hz. The resonances for Cys-CH2 and 7-Glu CH2 were broad at this
pH*. Resonances due to protons of C6H5 groups of dppe were broad at both pH values. The
resonances of the CH2 protons of dppe appeared as a set of three multiplets at acidic pH and at
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higher pH* they gave rise to two multiplets. Added GSH gave rise to a separate set of sharp
resonances and so exchange with free GSH was not the cause of the broadening. Instead, this is
probably due to the presence of coordination equilibria in solution. Spectra for 2 and 4 were
complicated by the presence of two isomeric products, as discussed above, and so are not
reported.
13C NMR data for the complexes [Pd(L-L’)(GS)CI] (L-L" dppe 3 L-L" dadpe 4) at low and
neutral pH* values are given in Table 4(a). The assignments for complex 3 are made partly on the
basis of a comparison of the changes in shifts of the resonances on increasing the pH* from 1.8
to 7.2 with those observed for free GSH, and on the shifts noted previously for the Cys carbons
of a 2"1 solution of GSH and Hg(NO3)2 in this pH* range.2 At pH* 7.2, three sets of broad
resonances were observed in the phenyl region corresponding to the C6H5 carbons of dppe. The
spectrum of the glutathione carbons of complex 4 was similar except that there were three
resonances in the Cys (x-CONH region at 172.5, 172.9, and 173.3 ppm. The resonances at
36.23 and 30.93 ppm are assigned to the aliphatic carbons adjacent to As and P, respectively.
The latter resonance is a doublet with JP-C 27 Hz. There were several resonances in the aromatic
region of the spectrum corresponding to C6H5 of dadpe.
The coordination chemical shifts of the carbon atoms are listed in Table 4(b). The greatest shift
observed is for the I-CH2 carbons of Cys which are shifted downfield by 7 to 8.6 p.p.m confirming
coordination of the adjacent S atom. In addition the x-CH carbons of Cys show an upfield shift of
1.6 p.p.m.. The resonances assigned to the Cys (x-CONH are also shifted upfield (2.2 to 2.4
p.p.m.) as are the resonances of the Glu 7-CONH (1.0 to 1.3 p.p.m.) suggesting interactions
between the NH or CO groups and the metal centre. The coordination shifts are independent of
pH* with the exception of those of the Glu x-COOH which is higher at pH* 7.2, perhaps
because the coordination of the metal affects the pKa of the carboxylic acid group. The
magnitudes of the coordination shifts for complexes 3 and 4 are similar, suggesting a similar
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Cytotoxic Phosphinoarsino andDiphosphino Pd(lI) Complexes
ofThiolateAmino Acids and Gluthathione
A previous study of Pd(ll) GSH complexes suggested coordination via S and N of the Cys residue
based on IR, UV-visible and analytical data, as well as the presence of bridging chloride ligands.’
Another study of a 1:1 complex suggested the formation of a seven-membered ring involving Pd,
the terminal amino group and the deprotonated NH of the first peptide bond (Cys) in the case of
the 1:1 Pd: GSH. Competition between S, N, CI and O ligands is therefore likely to be facile on
Pd(ll) accounting for the mixtures of species that are sometimes observed in solution.
The glutathione complexes, 3 and 4, [Pd(L-L)(GS.HCI)CI], were tested for toxicity against three
cell-lines: the murine cell-lines L1210 and ADJ/PC6, and the normal human ovarian cell-line CHI.
The compounds had a relatively low toxicity against the murine cell-lines, Figure 1A, e.g. towards
L1210 the IC50 values for 3 and 4 were ca. 22 and 32 IM respectively. However, they showed
some tissue selectivity against CH1 cells with IC50 values in the region of 4 to 10 IM (cf cisplatin
IC50 10 -7 gM agains this cell-line). They were mm cotoxic towards L1210 cells than the
bisthiolate complexes we have investigated previously, [Pd(dppe)(dmsa)] and
[Pd(dadpe)(dmsa)],2 and of comparable cytotoxicity to the square-planar dichloro complexes,
[Pd(L-L’)CI2], as shown in Figure lB. However there is no increase in the cytotoxicity of the
complexed ligand dppe or dadpe with respect to that of the free ligand towards this cell-line.
Indeed, for dppe the ligand itself is significantly more toxic (by up to 5 times).
CONCLUSION
By introducing thiolato ligands into Pd(ll) dppe and dadpe complexes, we have improved their
aqueous solubility and retained their cytotoxicities in comparison to the parent dichloro
complexes. For the L-cysteine complexes 1 and 2, IR and NMR showed the presence of S-bound
cysteine ligands, and there was evidence for both monomers containing S,N chelates and dimers
with bridging S in solution. Depending on the conditions, glutathione also bound strongly via S in
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(A) Cytotoxicities of Pd(ll) glutathione complexes towards three cell lines
(B) Cytotoxicities of dppe and dadpe Pd(ll) complexes of glutathione (GSH), dimercaptosuccinic
acid (H2drnsa) towards L1210 cells compared to those of the free ligands dppe, dadpe, and their
Pd(ll) dichlom complexes.
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complexes 3 and 4 and S-bridged complexes appeared to predominate in aqueous solution, but
complicated equilibria were also detected with evidence for exchange between various
coordination sites. Complexes with moderate cytotoxicity such as those described here, if they
are also active in vivo, could be useful in combination therapy with established drugs such as
cisplatin since they are likely to have a different mechanism of action.
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